Cogentech is offering its diagnostic services for Hereditary Tumors (Cancer Risk) and for Personalized Medicine (Therapy) to clinicians, laboratories and hospitals.
The excellence of our diagnostic services is based on highly qualified staff, decennial experience, continuous formation and innovation, adherence to high quality standards and commitment to provide the best possible diagnostic service possible.
Our diagnostic Lab has worked, first as a research group, and since 2011 in Cogentech SB Srl as a diagnostic service lab, in BRCA1/2 mutation analysis. Up to now we have provided more than 17.000 patients with a test result for genetic cancer risk.
We continuously innovate and improve our portfolio thanks to intense interaction with our holding company, the cancer research institute IFOM ETS and with our clients.
For our services we use both proprietary solutions (OncoPan®, OncoPed, OncoHRD, Sanger Sequencing) and commercial kits (MLPA, MS-MLPA) to provide the best diagnostic solutions.
We currently serve the main public and some private hospitals in the Lombardy region.
CGT Lab Service Charter Click here
List of Hereditary Cancer Syndromes and genes that are covered by OncoPan® Click here
List of Pediatric and Rare Cancer Syndromes and genes that are covered by OncoPed.Click here
List of Diagnostic Solutions for PARP inhibitor Therapy. Click here
List of MLPA and MS-MLPA analysis Click here